Maintenance of pluripotency in mouse ES cells without Trp53

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Shigeta, Masaki ^a   Ohtsuka, Satoshi ^a   Nishikawa Torikai, Satomi ^a   Yamane, Mariko ^a   Fujii, Setsuko ^a   Murakami, Kazuhiro ^a   Niwa, Hitoshi ^a,b,c  

^a RIKEN   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; PROTEIN P53;

ANEUPLOIDY; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CHIMERA; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE ORDER; GENE TARGETING; GENETICS; GENOTYPE; KARYOTYPING; METABOLISM; MOUSE; PROTEIN TRANSPORT;

ANEUPLOIDY; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CHIMERA; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKOUT TECHNIQUES; GENE ORDER; GENE TARGETING; GENOTYPE; KARYOTYPING; LEUKEMIA INHIBITORY FACTOR; MICE; PROTEIN TRANSPORT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84903681954     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02944     Document Type: Article

References (42)

1. Vousden, K. H. & Prives, C. Blinded by the Light: The Growing Complexity of p53. Cell 137, 413-31 (2009).
2. Zhao, T. & Xu, Y. p53 and stem cells: new developments and new concerns. Trends Cell Biol 20, 170-5 (2010).
3. Kruse, J. P. & Gu, W. Modes of p53 regulation. Cell 137, 609-22 (2009).
4. Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-6 (1981).
5. Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78, 7634-8 (1981).
6. Smith, A. G. et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-90 (1988).
7. Bradley, A., Evans, M., Kaufman, M. H. & Robertson, E. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-6 (1984).
8. Solozobova, V., Rolletschek, A. & Blattner, C. Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage. BMC Cell Biol 10, 46 (2009).
9. Solozobova, V. & Blattner, C. Regulation of p53 in embryonic stem cells. Exp Cell Res 316, 2434-46 (2010).
10. Lin, T. et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7, 165-71 (2005).
11. Han, M. K. et al. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2, 241-51 (2008).
12. Ungewitter, E. & Scrable, H. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs. Genes Dev 24, 2408-19 (2010).
13. Lee, D. F. et al. Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling. Cell Stem Cell 11, 179-94 (2012).
14. Aladjem, M. I. et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 8, 145-55 (1998).
15. Savatier, P., Huang, S., Szekely, L., Wiman, K. G. & Samarut, J. Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9, 809-18 (1994).
16. Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-21 (1992).
17. Niwa, H., Burdon, T., Chambers, I. & Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12, 2048-60 (1998).
18. Takeda, K. et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 94, 3801-4 (1997).
19. Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-23 (2008).
20. Toyooka, Y., Shimosato, D., Murakami, K., Takahashi, K. & Niwa, H. Identification and characterization of subpopulations in undifferentiated ES cell culture. Development 135, 909-18 (2008).
21. Nakai-Futatsugi, Y. & Niwa, H. Transcription Factor Network in Embryonic Stem Cells: Heterogeneity under the Stringency. Biol Pharm Bull 36, 166-70 (2013).
22. Wilkinson, D. G., Bhatt, S. & Herrmann, B. G. Expression pattern of the mouse T gene and its role in mesoderm formation. Nature 343, 657-9 (1990).
23. de Stanchina, E. et al. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13, 523-35 (2004).
24. Friedrich, G. & Soriano, P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5, 1513-23 (1991).
25. Savatier, P., Lapillonne, H., van Grunsven, L. A., Rudkin, B. B. & Samarut, J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor upregulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12, 309-22 (1996).
26. Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487-98 (2008).
27. Pearce, J. J. & Evans, M. J. Mml, a mouse Mix-like gene expressed in the primitive streak. Mech Dev 87, 189-92 (1999).
28. Blum, M. et al. Gastrulation in the mouse: the role of the homeobox gene goosecoid. Cell 26, 1097-106 (1992).
29. Barnes, J. D., Crosby, J. L., Jones, C. M., Wright, C. V. & Hogan, B. L. Embryonic expression of Lim-1, the mouse homolog of Xenopus Xlim-1, suggests a role in lateral mesoderm differentiation and neurogenesis. Dev Biol 161, 168-78 (1994).
30. Morrisey, E. E., Ip, H. S., Lu, M. M. & Parmacek, M. S. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol 177, 309-22 (1996).
31. Hebert, J. M., Boyle, M. & Martin, G. R. mRNA localization studies suggest that murine FGF-5 plays a role in gastrulation. Development 112, 407-15 (1991).
32. Doetschman, T. C., Eistetter, H., Katz, M., Schmidt, W. & Kemler, R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87, 27-45 (1985).
33. Rossant, J. & Tam, P. P. Blastocyst lineage formation, early embryonic asymmetries and axis patterning in the mouse. Development 136, 701-13 (2009).
34. Nichols, J. & Smith, A. Pluripotency in the embryo and in culture. Cold Spring Harb Perspect Biol 4, a008128 (2012).
35. Niwa, H. How is pluripotency determined and maintained? Development 134, 635-46 (2007).
36. Niwa, H. Mouse ES cell culture system as a model of development. Dev Growth Differ 52, 275-83 (2010).
37. Nishikawa, S. I., Nishikawa, S., Hirashima, M., Matsuyoshi, N. & Kodama, H. Progressive lineage analysis by cell sorting and culture identifies FLK1 + VEcadherin + cells at a diverging point of endothelial and hemopoietic lineages. Development 125, 1747-57 (1998).
38. Ying, Q. L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 21, 183-6 (2003).
39. Yan, P. et al. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res Commun 379, 115-20 (2009).
40. Navarro, P. et al. OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells. Embo J 31, 4547-62 (2012).
41. Talos, F., Nemajerova, A., Flores, E. R., Petrenko, O. & Moll, U. M. p73 suppresses polyploidy and aneuploidy in the absence of functional p53. Mol Cell 27, 647-59 (2007).
42. Ohtsuka, S., Nishikawa-Torikai, S. & Niwa, H. E-cadherin promotes incorporation of mouse epiblast stem cells into normal development. PLoS One 7, e45220 (2012).